▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / MDNC

MDNC — Medinotec Inc.

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 1931055 · South Africa
Last close
$5.00
Market Cap
$58.78M
52W High
$5.00
52W Low
$5.00
ADV30
0
Next earnings
—
Medinotec Inc. engages in the research and development, production, and sale of medical devices for the treatment of vascular and airway diseases in South Africa, the United States, and internationally. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. Medinotec Inc. was incorporated in 2021 and is headquartered in Johannesburg, South Africa.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Nov 2025 2,536,994 1,346,052 552,712 403,411 6,852,928 2,856,926 1,352,691
May 2025 2,134,026 925,331 277,457 113,784 7,404,026 1,950,876 3,035,204
Feb 2025 3,525,162 2,386,320 1,998,970 1,477,209 6,808,973 2,769,686 2,538,144
Nov 2024 2,565,048 1,040,776 513,767 310,311 5,362,621 2,676,525 2,536,789

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$27,127
Investing CF
$-71,280
Financing CF
$-201,042
CapEx
$-84,304
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.09
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,781,876
Inventory
$1,212,820
Receivables
$2,280,164
ST Investments
—
EBIT TTM
$3,320,801
Pretax Income TTM
$3,210,451
Interest Exp TTM
$110,350
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$11,432,487
EBITDA
$3,339,877
Free Cash Flow
$650,340
Enterprise Value
$55,943,136
Total Cash
$2,856,926
Total Debt
$22,320
Shares Out
11,755,548
Trailing EPS
$0.18
Book Value
$0.47
ROE
56.2%
ROA
34.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Feb 2025 9,113,607 3,191,499 2,159,473 6,808,973 2,538,144 — 877,834
Feb 2024 5,020,391 -41,434 -404,688 4,804,279 2,637,108 — 14,242
Feb 2023 999,579 -238,587 -352,735 4,490,432 1,934,377 — -490,549
Feb 2022 — — — 1,323,031 1,793,016 — —

Peers — same industry

TickerNameMarket CapLastDaily %
POSC POSITRON CORP $60.76M $1.85 —
APT ALPHA PRO TECH LTD $61.81M $6.05 —
DRIO DarioHealth Corp. $54.92M $7.51 —
POCI PRECISION OPTICS CORPORATION, INC. $54.40M $4.97 —
COCH Envoy Medical, Inc. $53.82M $0.70 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →